Cadent Capital Advisors’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-28,268
Closed -$1.6M 191
2025
Q3
$1.6M Buy
+28,268
New +$1.45M 0.42% 60
2025
Q1
Sell
-72,160
Closed -$1.74M 151
2024
Q4
$1.74M Buy
72,160
+1,060
+1% +$26.3K 0.6% 45
2024
Q3
$1.31M Buy
+71,100
New +$1.27M 0.4% 49

Other funds holding HIMS

Cadent Capital Advisors's HIMS Position: Q4 2025 in Review

Cadent Capital Advisors sold out of Hims & Hers Health (HIMS) in Q4 2025, closing a stake of 28,268 shares — an estimated $1.6M sold.

Cadent Capital Advisors first reported a position in HIMS in Q3 2024 and held it in 3 quarters. The position peaked at $1.74M in Q4 2024. 486 funds tracked by Wall St. Rank hold HIMS as of Q4 2025.

  • Cadent Capital Advisors reported no remaining Hims & Hers Health position as of Q4 2025 after selling out during the quarter.
  • Cadent Capital Advisors sold 28,268 Hims & Hers Health shares in Q4 2025, an estimated $1.6M.
  • Cadent Capital Advisors first reported a position in Hims & Hers Health in Q3 2024 and held it in 3 quarters.
  • Cadent Capital Advisors's Hims & Hers Health position peaked at $1.74M in Q4 2024.
  • 486 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2025.

Based on Cadent Capital Advisors's 13F filing for Q4 2025, filed 13 Jan 2026.